Spirometer market size accounted for $1.07 billion in 2019, and is expected to reach $1.47 billion by 2027, registering a CAGR of 3.5% from 2020 to 2027. Spirometer is used in assisting a patient who is having difficulty in breathing and cannot achieve adequate oxygen levels. Furthermore, patients with respiratory disorders such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and acute respiratory distress syndrome require COPD and asthma diagnostic and monitoring devices. In addition, growth in geriatric population, tobacco consumption, allergens, and air pollutants increase the prevalence of respiratory diseases, which in turn drive the global spirometer market.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
COSMED srl, Hill-Rom, Inc., MGC Diagnostic Corporation, Midmark Corporation, Nspire health Inc., SCHILLER, Smiths Medical, Teleflex Incorporated, Vitalograph, Vyaire medical
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/10967
On the basis of type, the table-top segment is estimated to garner largest share during the forecast period. This segment is expected to maintain its dominant position throughout the forecast period. Moreover, innovations in diagnostic devices have not only made it convenient to use them, but also made them portable and automatic. Furthermore, these advancements help clinical researchers and physicians in investigational studies. All these factors are expected to propel the growth of the market during the forecast period.
On the basis of technology, the flow measurement segment accounted for the largest share in 2019. This is attributed to the increasing use of flow measurement spirometer in pulmonary function testing applications for clinical diagnosis of COPD and asthma. These are smaller and portable, computerized and also help in minimizing infections. Thus, flow measurement technology is more desirable than spirometers with volume measurement technology and are expected to grow at the highest CAGR over the analysis period.
On the basis of application, the COPD segment garnered the largest share in 2019. It is expected to maintain its dominant position throughout the analysis period, owing to prevalence of asthma across the globe.
On the basis of end user, the hospital and clinics segment accounted for the highest share in 2019. It is expected to maintain its dominant position throughout the analysis period. This is attributed to rise in number of patients diagnosed with respiratory diseases, increase in government initiatives, and technological upgradation in spirometer devices. In addition, more than 5 million patients are admitted annually in the U.S.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/10967
Region wise, the spirometer market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to the factors such as rise in prevalence of respiratory diseases as a consequence of unhealthy lifestyles and high stress levels. Furthermore, incorporation of new reimbursement models for respiratory and monitoring solution procedures and stringent regulatory guidelines that are aimed toward medical efficacy, patient safety, and clinical efficiency are expected to drive the regional demand in the coming years. Furthermore, Asia-Pacific is anticipated to expand at a significant CAGR of 4.2% during the forecast period, owing to expeditiously improving healthcare systems and rise in healthcare expenditure and awareness regarding benefits of this technology.
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- By type, the table-top segment is anticipated to grow at a CAGR of 3.4% from 2020 to 2027.
- Based on end user, the hospitals & clinics segment dominated the spirometer market in 2019.
- By technology, the flow measurement segment accounted for the largest share in 2019 and is anticipated to grow at a CAGR of 70.5% throughout the forecast period.
- Based on application, the COPD segment garnered the largest share in 2019 and is expected to continue its dominance over the analysis period.
- Region wise, Asia-Pacific is anticipated to grow at a significant CAGR of 4.2% during the forecast period.
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Minimally Invasive Surgical Market
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com